Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » Blog » Cancer Options » Blog article: Proxcelan™ with Cesium-131 advantages

Proxcelan™ with Cesium-131 advantages

This Article was Written December 19th, 2007

Powered by Gregarious (39)

Proxcelan™ (Cesium-131) brachytherapy seeds offer patients unique advantages over other medical isotopes. Increasingly, prostate cancer patients and their doctors who decide on seed brachytherapy choose Cesium-131 treatment because of its significant advantages over Palladium-103 and Iodine-125, two other isotopes currently in use. These advantages include Higher Energy, Shorter Half-Life, and Higher Biologically Effective Dose.

For more information, visit www.proxcelan.com

Powered by Gregarious (39)

Share This Post - instructions included

PLEASE post a comment below

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    Caution Advised When Using Hormone Therapy for Prostate Cancer

  • In men with localized but aggressive prostate cancer, the combination of testosterone-lowering therapy and radiation improves survival substantially more than radiation therapy alone. But testosterone-lowering therapy isn’t so hot for the heart, reports the April issue of the Harvard Heart Letter. Low testosterone can increase harmful LDL cholesterol, blood sugar,

    • Welcome to the Cancer Options blog!

  • With this blog our goal is to lay a foundation for a site that helps answer different questions about cancer, treatments, technologies and much more. You'll be able to find articles from how to cope with a severe diagnosis to all the cancer options you have as far as treatments

    • Novel Therapy May Prove Effective In Treatment Of 30 Percent Of Cancers

  • Novel Therapy May Prove Effective In Treatment Of 30 Percent Of Cancers A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of

    • Brachytherapy of prostate cancer treatment and sterility

  • Posted: Sep 27th, 2009 | We'll talk about the relationship between Brachytherapy of prostate cancer treatment and sterility.Brachytherapy radiation through a direct effect or through indirect effects of free radicals was generated to destroy the DNA double-strand,Instead of splitting the tumor cells can survive longer.Generally cells in M phase and

    • Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins?

  • Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins? UroToday.com - In the online edition of the British Journal of Urology International, Dr. Rodrigo Frota presents the single surgeon laparoscopic radical prostatectomy (LRP) experience of Dr. Inderbir Gill. The study is a retrospective review with the intent

    • MRI combo spots prostate cancer treatment failure

  • Two imaging modalities used in combination -- dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI)-MRI -- can accurately spot residual or recurrent prostate cancer in patients treated with a fairly new treatment called high-intensity focused ultrasonic ablation, a new study shows.Together these two imaging modalities are better than

    • 5 Ways to Reduce the Risk of Prostate Cancer

  • Prostate cancer is one of the leading killers of men. The National Cancer Institute estimates that 186,320 men will be diagnosed with prostate cancer this year, and 28,660 will die from it. Although it’s one of the most common cancers suffered by men, there are ways to minimize the risk

    • ASTRO’s 49th annual meeting of radiation oncology

  • ProxcelanTM (Cesium-131) is the newest advancement in permanent brachytherapy seed implants for prostate cancerLOS ANGELES, CA - Several newly released scientific findings focusing on various aspects of ProxcelanTM (Cesium-131) seeds' effectiveness in the treatment of prostate cancer--supporting and broadening the growing body of evidence on the newest medical isotope being

    • About

  • IsoRay Medical™ was founded in Richland, Washington in 1998 to develop, manufacture and market isotopes for use in the medical treatment of various malignant diseases. Company founders included recognized experts in the medical isotope field, including Lane A. Bray, chief chemist of IsoRay Medical™, who developed the patented process for

    • ASTRO: Breast Brachytherapy Use Outpaces Evidence

  • By Charles Bankhead, Staff Writer, MedPage Today Published: November 06, 2009 Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston and Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner CHICAGO -- Use of brachytherapy to treat breast cancer continues to increase despite unresolved questions about long-term outcomes, according to data


  •  

    July 2010
    M T W T F S S
    « Jan    
     1234
    567891011
    12131415161718
    19202122232425
    262728293031  
images